These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
474 related items for PubMed ID: 11051374
21. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis. Ständer M, Peraud A, Leroch B, Kreth FW. Cancer; 2004 Sep 01; 101(5):1028-35. PubMed ID: 15329912 [Abstract] [Full Text] [Related]
22. TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers. Le Calvez F, Mukeria A, Hunt JD, Kelm O, Hung RJ, Tanière P, Brennan P, Boffetta P, Zaridze DG, Hainaut P. Cancer Res; 2005 Jun 15; 65(12):5076-83. PubMed ID: 15958551 [Abstract] [Full Text] [Related]
23. Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality. Al-Mulla F, Going JJ, Sowden ET, Winter A, Pickford IR, Birnie GD. J Pathol; 1998 Jun 15; 185(2):130-8. PubMed ID: 9713338 [Abstract] [Full Text] [Related]
24. Ki-ras mutation type and the survival benefit from adjuvant chemotherapy in Dukes' C colorectal cancer. Gnanasampanthan G, Elsaleh H, McCaul K, Iacopetta B. J Pathol; 2001 Dec 15; 195(5):543-8. PubMed ID: 11745689 [Abstract] [Full Text] [Related]
36. Immunohistological p53 staining is of limited value in the staging and prognostic prediction of colorectal cancer. Kressner U, Lindmark G, Gerdin B, Påhlman L, Glimelius B. Anticancer Res; 1996 May 15; 16(2):951-7. PubMed ID: 8687158 [Abstract] [Full Text] [Related]